布桂嗪预防肝穿活检术中疼痛的临床观察  

Clinical Observation of Bucinperazine for Severe Pain during Interventional Therapy

作　　者：陈昕[1] 邓洪梅[2] 张纪良[3] 袁泉[4] 贾钰铭[1] 

机构地区：[1]四川省宜宾市第二人民医院肿瘤科,644000 [2]四川省宜宾市第二人民医院五官科,644000 [3]四川省成都市第七人民医院肿瘤科,610041 [4]四川省宜宾市第二人民医院肛肠科,644000

出　　处：《中国医药指南》2009年第15期16-17,共2页Guide of China Medicine

摘　　要：目的探讨用布桂嗪预防肝穿活检术中疼痛的止痛作用及安全性。方法采用随机对照研究的方法,将40例行肝穿活检术的患者随机分为治疗组和对照组,治疗组(布桂嗪预防使用组)在肝穿活检术前予以布桂嗪100mg,对照组在肝穿活检术前不予以任何止痛处理进行痛视觉评分(VAS),观察两组患者肝穿活检术中中重度疼痛的比例,进行统计学分析。结果治疗组(布桂嗪预防使用组)中重度疼痛的发生率为5%,对照组中重度疼痛的发生率为30%。两组差异有统计学意义。结论布桂嗪对肝穿活检术的疼痛有较好的预防止痛效果且较迅速、安全,为肝穿活检术中的疼痛提供了一个好的止痛方法。Objective To study bucinperazine＇ s ability of preventing the severe pain during liver mass biopsy. Methods 40 cases patients were randomly divided into treat group and control group. Bucinperazine was used in treat group. Nothing was used in control group. Results The rate of severe pain of treat group was 5%. The rate of severe pain of control group was 30%. The rate of severe pain of treat group were statistical different with the control group （P〈0.05）. Conclusion bucinperazine may effectively prevent the severe pain during liver mass biopsy.

关 键 词：布桂嗪 恶性肿瘤 肝穿活检术 疼痛 

分 类 号：R73[医药卫生—肿瘤]